Page last updated: 2024-12-11

tytin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

tytin: composed of Ag, Cu, Sn [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6367220
MeSH IDM0111980

Synonyms (2)

Synonym
tytin
63807-68-1

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Dispersalloy (Johnson and Johnson) was severely cytotoxic initially when Zn release was greatest, but was less toxic between 48 and 72 h as Zn release decreased."( Correlation of cytotoxicity with element release from mercury- and gallium-based dental alloys in vitro.
Hanks, CT; Nakajima, H; Okabe, T; Wataha, JC, 1994
)
0.29
"05) less toxic than the other amalgams, and not different from the Teflon control."( In vitro cytotoxicity of amalgams made with binary Hg-In liquid alloys.
Nakajima, H; Okabe, T; Rockwell, LC; Wataha, JC, 1997
)
0.3
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (120)

TimeframeStudies, This Drug (%)All Drugs %
pre-199015 (12.50)18.7374
1990's75 (62.50)18.2507
2000's24 (20.00)29.6817
2010's6 (5.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 30.59

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index30.59 (24.57)
Research Supply Index5.19 (2.92)
Research Growth Index4.85 (4.65)
Search Engine Demand Index50.43 (26.88)
Search Engine Supply Index2.53 (0.95)

This Compound (30.59)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials20 (12.66%)5.53%
Reviews1 (0.63%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other137 (86.71%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]